Emerging SARS-CoV-2 variants expand species tropism to murines
2021 · EBioMedicine · 189 citations
https://doi.org/10.1016/j.ebiom.2021.103643
Y
Yuxin Hou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
67
Papers
4.6K
Citations
29
h-index
38
i10-index
Yuxin Hou is an academic researcher from Hangzhou Normal University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Carbon and Quantum Dots Applications. The author has an h-index of 29, co-authored 57 publications.
ORCID: 0000-0003-0380-5288Papers by this author
worksHost and viral determinants for efficient SARS-CoV-2 infection of the human lung
2021 · Nature Communications · 153 citations
https://doi.org/10.1038/s41467-020-20457-w
An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron
2022 · Nature Microbiology · 99 citations
https://doi.org/10.1038/s41564-022-01119-7
A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants
2023 · Signal Transduction and Targeted Therapy · 79 citations
https://doi.org/10.1038/s41392-023-01392-w
Virological features and pathogenicity of SARS-CoV-2 Omicron BA.2
2022 · Cell Reports Medicine · 47 citations
https://doi.org/10.1016/j.xcrm.2022.100743
Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3
2024 · Nature Communications · 44 citations
https://doi.org/10.1038/s41467-024-53033-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat